Медицинская библиотека · Journal of the American Heart Association · 2026

Comprehensive Diagnostic Evaluation and Risk of Recurrent Stroke After Embolic Stroke of Undetermined Source: Introducing the Concept of ESUS 2.0.

Khan Farhan, Stretz Christoph, Lewis Skylar, Chahien Dalia, Goldstein Eric, Siegler James E, Lineback Christina M, Eklund Kelsey, Khasiyev Farid, Al Kasab Sami, Culbertson Collin J, D'Souza Marissa, Stamm Brian, Ro Jennifer, Kerrigan Deborah, Sharma Richa, Aboul-Nour Hassan, Nahab Fadi, Omran Setareh Salehi, Linares Guillermo, Sehgal Siddharth, Melkumova Emiliya, Singh Eesha, Zha Alicia M, Thottempudi Neeharika, Mannion Shani, Van Coevering Russel, Chen Lucia, Thompson Sean L, Thon Jesse M, Penckofer Mary, Yu Wenzheng, Qdais Ahmad Abu, Jillella Dinesh, Sloane Kelly L, Dumitrascu Oana M, Conyers Frank G, Talat Fawad, Glover Patrick A, Kang Jieun, Patel Vivek, Aziz Yasmin, Zubair Adeel, de Havenon Adam, Porto Camelia Valhuerdi, Bowman Anna, Shahrivari Mahan, Brorson James R, Liebeskind David S, Nedelcu Simona, Ali Hamid, Abdalwahab Ahmed, Kam Wayneho, Nguyen Thanh N, Herpich Franziska, Farroqui Mudassir, Rojas-Soto Diana, Yaghi Shadi

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Although the embolic stroke of undetermined source (ESUS) construct was proposed as a unifying concept for embolic-appearing strokes without an identified cause, it includes patients with diverse and often unrecognized underlying mechanisms. This study investigates the differential rate of recurrent stroke according to the completeness of neurodiagnostic testing in a diverse multicenter cohort.

METHODS

This was a retrospective analysis of a multicenter observational cohort study (n=27 sites). ESUS was categorized into 3 groups: (1) established mechanism after further workup (ESUS-E), (2) comprehensive diagnostic workup without an identified cause (ESUS 2.0), and (3) no advanced workup. The primary outcome of recurrent ischemic stroke was compared between ESUS with established mechanism and ESUS 2.0 versus ESUS with no advanced workup and was assessed using adjusted Cox proportional hazards models.

RESULTS

Among 2281 patients, the mean age was 65 years, and 50.1% were men. 694 (30.4%) classified as ESUS-E, 1,243 (54.5%) classified as ESUS-NAW, and 344 (15.1%) as ESUS 2.0. The ESUS 2.0 group had a significantly lower risk of recurrent stroke than both the group with ESUS with no advanced workup (adjusted hazard ratio [aHR], 0.31 [95% CI, 0.13-0.76]) and the group with ESUS with established mechanism (aHR, 0.35 [95% CI, 0.15-0.85]). Within the group with ESUS with established mechanism, cancer (aHR, 5.33 [95% CI, 2.09-13.63]) and nonstenosing atherosclerotic disease or arch atheroma (aHR, 3.40 [95% CI, 1.18-9.83]) were associated with significantly increased risk of recurrence when compared with the group with ESUS 2.0.

CONCLUSIONS

These findings demonstrate a lower risk of recurrent stroke in patients classified as ESUS 2.0 than reported in prior ESUS trials and highlight the importance of age-appropriate advanced diagnostic evaluation.

REGISTRATION: URL: https://www.clinicaltrials.gov. Identifier: NCT06398366.

Для цитирования: Khan Farhan, Stretz Christoph, Lewis Skylar, Chahien Dalia, Goldstein Eric, Siegler James E, Lineback Christina M, Eklund Kelsey, Khasiyev Farid, Al Kasab Sami, Culbertson Collin J, D'Souza Marissa, Stamm Brian, Ro Jennifer, Kerrigan Deborah, Sharma Richa, Aboul-Nour Hassan, Nahab Fadi, Omran Setareh Salehi, Linares Guillermo, Sehgal Siddharth, Melkumova Emiliya, Singh Eesha, Zha Alicia M, Thottempudi Neeharika, Mannion Shani, Van Coevering Russel, Chen Lucia, Thompson Sean L, Thon Jesse M, Penckofer Mary, Yu Wenzheng, Qdais Ahmad Abu, Jillella Dinesh, Sloane Kelly L, Dumitrascu Oana M, Conyers Frank G, Talat Fawad, Glover Patrick A, Kang Jieun, Patel Vivek, Aziz Yasmin, Zubair Adeel, de Havenon Adam, Porto Camelia Valhuerdi, Bowman Anna, Shahrivari Mahan, Brorson James R, Liebeskind David S, Nedelcu Simona, Ali Hamid, Abdalwahab Ahmed, Kam Wayneho, Nguyen Thanh N, Herpich Franziska, Farroqui Mudassir, Rojas-Soto Diana, Yaghi Shadi. Comprehensive Diagnostic Evaluation and Risk of Recurrent Stroke After Embolic Stroke of Undetermined Source: Introducing the Concept of ESUS 2.0.. Journal of the American Heart Association. 2026. DOI: 10.1161/jaha.126.050182.

Предметные рубрики MeSH

Humans Male Recurrence Retrospective Studies Female Embolic Stroke Aged Risk Factors Risk Assessment Middle Aged Predictive Value of Tests Ischemic Stroke Stroke

Подготовка и перевод публикации

Обработка статьи · этапы, ошибки и управление

Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.